Virginia Retirement Systems’s Stoke Therapeutics STOK Stock Holding History

Virginia Retirement Systems’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$443K	Buy	13,550 +2,900	+27%	+$93.1K	﹤0.01%	1001
2026 Q1	$347K	Buy	10,650 +4,100	+63%	+$134K	﹤0.01%	831
2025 Q4	$208K	Buy	+6,550	New	+$197K	﹤0.01%	912
2023 Q3	$58.7K	Sell	14,900 -700	-4%	-$4.6K	﹤0.01%	932
2023 Q2	$166K	Sell	15,600 -300	-2%	-$3.19K	﹤0.01%	933
2023 Q1	$132K	Sell	15,900 -1,200	-7%	-$10.8K	﹤0.01%	989
2022 Q4	$158K	Buy	17,100 +1,900	+13%	+$19.8K	﹤0.01%	1074
2022 Q3	$195K	Buy	+15,200	New	+$242K	﹤0.01%	1062
2022 Q1	$322K	Buy	+15,300	New	+$306K	﹤0.01%	959

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virginia Retirement Systems's STOK Position: Q2 2026 in Review

Virginia Retirement Systems increased its Stoke Therapeutics (STOK) stake by 27% in Q2 2026, buying an estimated $93.1K and bringing the position to 13,550 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Virginia Retirement Systems first reported a position in STOK in Q1 2022 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Virginia Retirement Systems held 13,550 shares of Stoke Therapeutics worth $443K as of Q2 2026.
Virginia Retirement Systems bought 2,900 Stoke Therapeutics shares in Q2 2026, an estimated $93.1K.
Stoke Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1001 holding.
Virginia Retirement Systems first reported a position in Stoke Therapeutics in Q1 2022 and has held it in 9 quarters since.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.